Patti, Giuseppe <br/><br/>
Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.  [electronic resource] 

 -  Journal of the American College of Cardiology  Oct 2006 
 - 1560-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1558-3597 
<br/><br/><label>Standard No.: </label>10.1016/j.jacc.2006.06.061  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angina Pectoris--blood<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Atorvastatin<br/>Cardiotonic Agents--therapeutic use<br/>Cell Adhesion Molecules--blood<br/>Coronary Disease--blood<br/>E-Selectin--blood<br/>Heart Injuries--epidemiology<br/>Heptanoic Acids--therapeutic use<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Incidence<br/>Intercellular Adhesion Molecule-1--blood<br/>Multicenter Studies as Topic<br/>Pyrroles--therapeutic use<br/>Vascular Cell Adhesion Molecule-1--blood